Filing Flows › Korro Bio (KRRO) › Who owns the stock
Who owns Korro Bio (KRRO) stock
103 funds reported Korro Bio (KRRO) shares in their latest 13F filings, worth $218M in all. The largest holder is Lynx1 Capital Management LP ($20.3M). Last quarter 44 funds added to their stakes and 42 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Lynx1 Capital Management LP | 1,538,296 | $20.3M | unchanged | 2026-06-30 |
| Qiming U.S. Ventures Management, LLC | 368,085 | $17.6M | unchanged | 2025-09-30 |
| Nantahala Capital Management, LLC | 1,320,072 | $17.4M | increase | 2026-06-30 |
| NEA Management Company, LLC | 1,297,893 | $17.1M | unchanged | 2026-06-30 |
| VR Adviser, LLC | 1,009,500 | $13.3M | unchanged | 2026-06-30 |
| Atlas Venture Life Science Advisors, LLC | 962,884 | $12.7M | decrease | 2026-06-30 |
| Balyasny Asset Management L.P. | 951,783 | $12.5M | decrease | 2026-06-30 |
| BlackRock | 817,621 | $10.8M | increase | 2026-06-30 |
| Affinity Asset Advisors, LLC | 706,904 | $9.3M | unchanged | 2026-06-30 |
| Adage Capital Partners GP, L.L.C. | 540,968 | $7.1M | increase | 2026-06-30 |
| ADAR1 Capital Management, LLC | 540,054 | $7.1M | unchanged | 2026-06-30 |
| Vanguard Capital Management LLC | 454,778 | $6.0M | increase | 2026-06-30 |
| Driehaus Capital Management LLC | 450,045 | $5.9M | unchanged | 2026-06-30 |
| TCG Crossover Management, LLC | 416,301 | $5.5M | unchanged | 2026-06-30 |
| Kalehua Capital Management LLC | 405,040 | $5.3M | increase | 2026-06-30 |
Korro Bio's latest quarter
Korro Bio, Q4 2025: revenue $1.3M (-43% year over year), net loss $50.0M, operating cash flow −$17.7M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most KRRO stock?
By the latest 13F filings: Lynx1 Capital Management LP ($20.3M); Qiming U.S. Ventures Management, LLC ($17.6M); Nantahala Capital Management, LLC ($17.4M); NEA Management Company, LLC ($17.1M); VR Adviser, LLC ($13.3M).
What is the short interest in KRRO?
1,732,855 shares were sold short at the 2026-10-15 settlement, 3.44% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.